NEW YORK (GenomeWeb) – Caprion said today it has received a grant from the Michael J. Fox Foundation for Parkinson's Research to identify protein biomarkers associated with Parkinson's.

The Montreal-based firm said it will use the funding to identify and validate biomarkers that could be used for early detection and diagnosis, monitor disease progression, and assess the effectiveness of experimental therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.